ArticleInternational journal of clinical oncology2026

Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis.

Makoto Nishio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.